Remote monitoring study for gout patients
Part of Bones, joints & muscles, Genetic & congenital, Hormones & metabolism clinical trials.
This study tests whether using a smartphone or tablet to monitor your gout from home can help manage the condition. You may qualify if you have had at least one gout flare in the last year and have high uric acid levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have a gout diagnosis
- You have had at least one gout flare in the past year
- Your uric acid level is above 360 µmol/L (a blood test can check this)
- You own a smartphone or tablet
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether nurse-led telehealth visits can help people with gout maintain healthy urate levels. If you have gout and are already on medication like allopurinol, this study may offer a convenient way to manage your condition from home.
This study tests whether a genetic test can help doctors choose the safest and most effective gout medication. It aims to prevent severe allergic reactions by personalizing treatment based on your genes.
This study tests whether a smartphone app can help your doctor monitor your gout and adjust your urate-lowering medication. It is a feasibility study, meaning it checks if the approach works well for patients.
This trial tests an investigational tablet called BR2251 to see if it can lower uric acid levels in people with gout and hyperuricemia (too much uric acid in the blood). If you qualify, you may get a new treatment that could help prevent painful gout attacks.
This study compares two different treatment goals for a blood level called urate in people with gout. The goal is to see which approach lowers gout flares better while helping people feel better.
This study looks at whether people with gout whose uric acid is well controlled and whose joints are clear on ultrasound can safely stop their daily uric acid-lowering medication. Participants are randomly assigned to either continue their current medication or stop it, and their health is monitored to see if stopping leads to gout flares or joint damage.
Hear when a new Gout Initiating Urate-loweringUrate-lowering Therapy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.